2022 annual financial data
CytoMed Therapeutics 2022 Operating margin
Direct answer
Operating margin was -624.51%.
Operating income was -2,283,246 SGD and net income was -3,055,471 SGD.
Operating cash flow was -1,404,918 SGD.
Get free CytoMed Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 365,604 SGD
- Operating income
- -2,283,246 SGD
- Net income
- -3,055,471 SGD
- Operating cash flow
- -1,404,918 SGD